NEW YORK (GenomeWeb) – GeneNews yesterday after the close of the market reported a sharp increase year over year in its fourth quarter revenues.

For the three months ended Dec. 31, 2014, GeneNews' total revenues jumped to C$701,000 (US$555,844) from C$37,000 in the prior-year period.

The firm attributed the growth in revenue to a 50 percent increase in ColonSentry test volume in the second half of the fiscal year. The firm's jointly owned US Innovative Diagnostic Laboratory processed 14,387 ColonSentry tests in Q4 2014. The firm has a 33 percent share in the joint venture.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.

NPR reports that government and private insurers are being slow to cover recently approved CAR-T cell therapies.

CNBC reports that there are thousands of genetic tests available for consumers to chose between.

In Nature this week: genomic analysis of ducks, whole-genome doubling among tumor samples, and more.